ClinicalTrials.gg
Drug

Oxybutynin clinical trials

Also written Oxytrol and Ditropan.

studies test it
56
open now
9
in phase 3
16
first study started
1995

How each study uses oxybutynin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the oxybutynin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Jul 1975 · DITROPAN · NDA 017577 (FDA, Drugs@FDA)
European Union
15 Jun 2004 · Kentera (previously Oxybutynin Nicobrand) · EMEA/H/C/000532 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Oxybutynin
23
Oxybutynin Chloride
4
Gelnique
3
Oxybutynin Chloride ER Tablets 10 mg
3
Oxybutynin ER
3

Brand

Oxytrol
4

Development codes

MJ-4309-1
1

Other names

Ditropan
4

In one entry with another drug

Given together, or one or the other

Atomoxetine and Oxybutynin (ato-oxy)
2

Studies by the year they started

55 studies that test it; most in 2002 (5)

Studies that test oxybutynin, by start year
YearStudies
19951
20025
20044
20051
20062
20073
20081
20094
20103
20112
20132
20142
20153
20164
20181
20192
20202
20213
20223
20231
20242
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
7
Phase 2
12
Phase 3
16
Phase 4
11
No phase
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 20 · Other 36

Mylan Pharmaceuticals Inc (5) · Watson Pharmaceuticals (4) · University of Arizona (2) · Brigham and Women's Hospital (2) · Alza Corporation, DE, USA (2) · University of Calgary (2) · Northwestern University (1) · China Medical University Hospital (1)

Often tested with

Tested in the same studies.

Atomoxetine (5) · Venlafaxine (2) · Tolterodine (2) · Botulinum toxin type A (2) · Solifenacin (2) · Methocarbamol (1) · Desloratadine (1) · Fesoterodine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test oxybutynin, phase 3 first.

Studies

Open first, then newest update. How each study uses oxybutynin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 56

See all 56 studies that test oxybutynin →

Given beside what is tested · 5 — oxybutynin is usual care or a partner of the new treatment
As the comparator · 13 — what is tested is compared with oxybutynin

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call oxybutynin · ClinicalTrials.gg INT002331

  • MeSH (NLM) C005419oxybutyninConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) K9P6MC7092OXYBUTYNINConfirmed FDA, NLM, Wikidata
  • RxNorm 32675Confirmed FDA, Wikidata
  • Wikidata Q1060922(RS)-oxybutyninConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47647OxybutyninOne source FDA
  • DrugBank DB01062One source Wikidata

Also registered as oxybutynin chloride (UNII L9F3D9RENQ · RxNorm 54251).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.